Research Update: Kidney Pill, New App, Stem Cell News
Finerenone, undergoing 2 clinical trials for safety and efficacy, is a new medication developed by Bayer that may help reduce markets of kidney malfunction called “proteinuria” (the presence of abnormal quantities of protein in the urine). Read more on DiaTribe.org:...
Afrezza UPDATE: Sanofi OUT, Receptor Life Sciences IN
On January 5, 2016, MannKind Corporation announced the termination of its license and collaboration agreement with Sanofi-Aventis, for development and commercialization of Afrezza, hoping for a smooth transition back to MannKind through the next 6 months. You can read...
What to Eat: 10 Commandments from Adam Brown of Diatribe
Should it be low carb? Should it have fats? How much protein? Adam Brown, a contributing editor of DiaTribe, posted 2 interesting articles. The first is his list of Ten Diet Commandments that he tries to follow daily. This is not a prescription nor a...
Sad News about Afrezza
MannKind Corporation today announced the termination of its license and collaboration agreement with Sanofi-Aventis U.S. LLC for the development and commercialization of Afrezza® (insulin human) Inhalation Powder. http://tinyurl.com/jkez5pw I am SO SAD! I’ve...
